Rare condition

Idiopathic ventricular fibrillation

3

studies recruiting now

as of 7 Sept 2026

6

studies registered in total

as of 7 Sept 2026

6

countries with a recruiting site

as of 7 Sept 2026

12 Feb 2026

most recent study posted

among recruiting studies

Recruiting trials

RecruitingNCT06943365

Role of Anti-TREK-1 Autoantibodies in SCVF

Sponsor Institut universitaire de cardiologie et de pneumologie de Québec, University LavalWhere Canada, Netherlands (5 sites)Studying Repeat plasma screening for the presence or absence of anti-TREK-1 autoantibodies, DPP6 risk haplotypeUpdated 16 Jun 2026

Showing the 3 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

Search all Idiopathic ventricular fibrillation studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Keep watching

Get an email when a new Idiopathic ventricular fibrillation study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Idiopathic ventricular fibrillation

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (SCN5A, DPP6).

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).